| Offering Information |
| Expected Date | - |
| Proposed Exchange/Ticker |
NYSE: SP |
| Security Type |
Common Stock |
| Lead Underwriter |
Merrill Lynch |
| Days In Registration |
86 |
| Date Filed |
12-Sep-2000 |
| Form Filed | S-1 |
Fundamentals
(Year Ending December 2007) |
| Industry |
Healthcare |
| Business Description |
Provide and perform esoteric clinical laboratory tests services as well as clinical reference laboratory |
| Revenue |
$153.2M |
| Net Income |
$8.7M |
| Shares Outstanding (post-offering) |
20.94M |
| Chairman and CEO |
James B.Peter, M.D., Ph.D. |
| Number of Employees |
798 |
|
| Original Filing Information |
| US |
| Shares Filed |
- |
| Secondary Shares Filed | - |
| · As a Percent |
- |
| Primary Shares Filed |
- |
| · As a Percent |
- |
| Overallotment Shares Filed |
750.0K |
| File Amount |
- |
| File Price Range |
$16.00 - $14.00 |
| File Mid Price |
$15.00 |
Current Filing Information
(Amended 5-Dec-2000) |
|
US |
|
Shares Filed |
5.0M |
| Secondary Shares Filed |
- |
| · As a Percent |
- |
| Primary Shares Filed |
5.0M |
| · As a Percent |
100.0 |
| Overallotment Shares Filed |
- |
| File Amount |
$75.0M |
| · % Change from Original |
|
| File Price Range |
$16.00 - $14.00 |
| File Mid Price |
$15.00 |
|
